Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Search results (2)

« Back to News

New Oxford-GSK Institute to harness advanced technology and unravel mechanisms of disease

7 December 2021

GlaxoSmithKline plc and the University of Oxford today announced a major five-year collaboration to establish the Oxford-GSK Institute of Molecular and Computational Medicine.

Director Professor John Todd awarded EASD-Novo Nordisk Foundation Diabetes Prize for Excellence

25 May 2021

Search results (2)

New Oxford-GSK Institute to harness advanced technology and unravel mechanisms of disease

Director Professor John Todd awarded EASD-Novo Nordisk Foundation Diabetes Prize for Excellence

Categories